全身多参数18F-FDG PET定量评估新冠病毒感染康复者葡萄糖转运与代谢
研究纳入13名健康者和12名确诊后8周内康复的新冠病毒感染者,行全身动态18F-FDG PET扫描并用示踪动力学建模定量葡萄糖转运与磷酸化。康复者肺部SUVR与净内流率显著升高、骨髓葡萄糖转运率显著升高,提示康复期持续炎症;接种疫苗者肺净内流率较低、脾较高。
要点
- 康复者肺部SUV无显著差异,但SUVR与净内流率显著升高,动力学定量更敏感。
- 肺部磷酸化率k3有显著差异而净内流率无显著差异,提示差异由磷酸化驱动。
- 骨髓SUV、SUVR及净内流率无或几乎无差异,但葡萄糖转运率显著升高。
核心结论
- 康复期新冠病毒感染者较健康者肺部葡萄糖代谢更高、骨髓葡萄糖转运更高,提示康复期持续炎症。
- 疫苗接种显示潜在保护效应。
- 全身多参数18F-FDG PET较常规全身静态显像更敏感,可提供更多代谢改变信息。
研究设计与样本
- 研究纳入13名健康受试者和12名确诊后8周内康复的新冠病毒感染者。
- 每名受试者在uEXPLORER全身PET/CT系统上行1小时动态18F-FDG扫描。
- 计算不同器官的半定量SUV及相对血池的SUV比值(SUVR),并行示踪动力学建模定量血液到组织的18F-FDG转运率、磷酸化率k3及净内流率。
- 行统计学检验比较健康者与康复者差异,并分析新冠病毒疫苗接种的影响。
主要发现
- 康复者肺部SUV无显著差异,但肺部SUVR和净内流率显著高于健康者。
- 肺部磷酸化率k3有显著差异,而净内流率无显著差异,提示葡萄糖磷酸化而非葡萄糖转运驱动所观察到的代谢差异。
- 骨髓18F-FDG代谢以SUV、SUVR和净内流率衡量无或几乎无差异,但康复者骨髓葡萄糖转运率显著升高。
- 接种疫苗的康复者较未接种者肺部净内流率更低、脾净内流率更高。
临床怎么用
- 作者认为,全身多参数18F-FDG PET可较常规全身静态18F-FDG显像提供更敏感的工具和更多信息,用于评估新冠病毒感染等系统性疾病的代谢改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Conventional whole-body static 18F-FDG PET imaging provides a semiquantitative evaluation of overall glucose metabolism without insight into the specific transport and metabolic steps. Here we demonstrate the ability of total-body multiparametric 18F-FDG PET to quantitatively evaluate glucose metabolism using macroparametric quantification and assess specific glucose delivery and phosphorylation processes using microparametric quantification for studying recovery from coronavirus disease 2019 (COVID-19). Methods: The study included 13 healthy subjects and 12 recovering COVID-19 subjects within 8 wk of confirmed diagnosis. Each subject had a 1-h dynamic 18F-FDG scan on the uEXPLORER total-body PET/CT system. Semiquantitative SUV and the SUV ratio relative to blood (SUVR) were calculated for different organs to measure glucose utilization. Tracer kinetic modeling was performed to quantify the microparametric blood-to-tissue 18F-FDG delivery rate [Formula: see text] and the phosphorylation rate k 3, as well as the macroparametric 18F-FDG net influx rate ([Formula: see text]). Statistical tests were performed to examine differences between healthy subjects and recovering COVID-19 subjects. The effect of COVID-19 vaccination was also investigated. Results: We detected no significant difference in lung SUV but significantly higher lung SUVR and [Formula: see text] in COVID-19 recovery, indicating improved sensitivity of kinetic quantification for detecting the difference in glucose metabolism. A significant difference was also observed in the lungs with the phosphorylation rate k 3 but not with [Formula: see text], which suggests that glucose phosphorylation, rather than glucose delivery, drives the observed difference of glucose metabolism. Meanwhile, there was no or little difference in bone marrow 18F-FDG metabolism measured with SUV, SUVR, and [Formula: see text] but a significantly higher bone marrow [Formula: see text] in the COVID-19 group, suggesting a difference in glucose delivery. Vaccinated COVID-19 subjects had a lower lung [Formula: see text] and a higher spleen [Formula: see text] than unvaccinated COVID-19 subjects. Conclusion: Higher lung glucose metabolism and bone marrow glucose delivery were observed with total-body multiparametric 18F-FDG PET in recovering COVID-19 subjects than in healthy subjects, implying continued inflammation during recovery. Vaccination demonstrated potential protection effects. Total-body multiparametric PET of 18F-FDG can provide a more sensitive tool and more insights than conventional whole-body static 18F-FDG imaging to evaluate metabolic changes in systemic diseases such as COVID-19.
引用
- Wang Y, Nardo L, Spencer BA, et al. Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery. J Nucl Med. 2023. PMID: 37591539. doi:10.2967/jnumed.123.265723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。